Clinical Trial Update: Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial updating on the effect of Vascepa (icosapent ethyl) on improving coronary atherosclerosis in people with high triglycerides on statin therapy; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• Hypertriglyceridemia

Drugs mentioned

• Vascepa (icosapent ethyl)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Hypertriglyceridemia | Phase 4 | Status: COMPLETED | Results posted: 2021-11-02